IONS
Ionis Pharmaceuticals Inc
43.90$
-4.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1.5% | 1.8% | 1.8% | 1.8% | 0.8% | 1.7% | 1.1% | 0.9% | 1.5% | 3.9% | 1.2% | 1.0% | 1.8% | |
| 98.5% | 98.2% | 98.2% | 98.2% | 99.2% | 98.3% | 98.9% | 99.1% | 98.5% | 96.1% | 98.8% | 99.0% | 98.2% | |
| 149.1% | 179.3% | 179.3% | 98.6% | 164.2% | 108.3% | 152.5% | 48.1% | 138.9% | 137.9% | 85.4% | 81.0% | 105.9% | |
| 48.5% | 44.1% | 44.1% | 28.9% | 46.0% | 38.9% | 58.0% | 20.0% | 61.8% | 64.1% | 61.1% | 56.1% | 60.4% | |
| 197.8% | 223.3% | 223.3% | 127.5% | 210.3% | 147.2% | 210.4% | 68.2% | 200.7% | 202.0% | 146.5% | 137.2% | 166.2% | |
| -99.3% | -125.1% | -125.1% | -29.3% | -111.1% | -48.9% | -111.6% | 30.9% | -102.2% | -105.9% | -47.7% | -38.2% | -68.1% | |
| 15.2% | 18.5% | 18.5% | 10.1% | 17.0% | 10.1% | 17.4% | 5.0% | 14.1% | 11.2% | 9.1% | 8.3% | 10.2% | |
| -97.6% | -119.4% | -119.4% | -29.4% | -107.7% | -47.2% | -111.6% | 27.3% | -81.9% | -112.3% | -37.5% | -42.3% | -64.3% | |
| 4.6% | 0.1% | 0.1% | 0.0% | -2.7% | -1.2% | 0.1% | 0.0% | 0.1% | 0.5% | 0.1% | -0.5% | 0.0% | |
| -102.2% | -119.5% | -119.5% | -29.4% | -105.0% | -46.1% | -111.6% | 27.3% | -82.1% | -112.8% | -37.6% | -42.8% | -64.6% | |
| -79.6% | -97.5% | -97.5% | -16.8% | -87.7% | -35.5% | -91.2% | 33.2% | -65.9% | 2,269.7% | -27.8% | -39.3% | 495.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.